Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis

CONCLUSIONS: The meta-analysis showed that nirmatrelvir/ritonavir and sotrovimab have similar effectiveness in treating COVID-19 patients. However, the certainty of evidence supporting these findings is low. High-quality research is needed to better compare these interventions in COVID-19.PMID:38457124 | DOI:10.1080/14787210.2024.2326561
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Source Type: research